1. van der Graaf, W, Orbach, D, Judson, I, Ferrari, A. Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. Lancet Oncol. 2017;18(3):e166‐e175. doi:10.1016/s1470-2045(17)30099-2
Google Scholar | Crossref | Medline2. Harati, K, Goertz, O, Pieper, A, et al. Soft tissue sarcomas of the extremities: surgical margins can be close as long as the resected tumor has no ink on it. Oncologist. 2017;22(11):1400-1410. doi:10.1634/theoncologist.2016-0498
Google Scholar | Crossref | Medline3. Callegaro, D, Miceli, R, Bonvalot, S, et al. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors. EClinicalMedicine. 2019;17:100215. doi:10.1016/j.eclinm.2019.11.008
Google Scholar | Crossref | Medline4. Brennan, M, Antonescu, C, Moraco, N, Singer, S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416-421. discussion 421-2. doi:10.1097/sla.0000000000000869
Google Scholar | Crossref | Medline5. Gamboa, A, Ethun, C, Switchenko, J, et al. Lung surveillance strategy for high-grade soft tissue sarcomas: chest x-ray or CT scan?. J Am Coll Surg. 2019;229(5):449-457. doi:10.1016/j.jamcollsurg.2019.07.010
Google Scholar | Crossref | Medline6. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma meta-analysis collaboration. J Lancet (London, England). 1997;350(9092):1647-1654.
Google Scholar | Crossref7. Iqbal, N, Shukla, N, Deo, S, et al. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients. Clin Transl Oncol. 2016;18(3):310-316. doi:10.1007/s12094-015-1369-9
Google Scholar | Crossref | Medline8. Bedi, M, King, D, Charlson, J, et al. Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. Am J Clin Oncol. 2014;37(3):272-277. doi:10.1097/COC.0b013e318277d7e5
Google Scholar | Crossref | Medline9. Stojadinovic, A, Leung, D, Hoos, A, Jaques, D, Lewis, J, Brennan, M. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235(3):424-434. doi:10.1097/00000658-200203000-00015
Google Scholar | Crossref | Medline | ISI10. Ueda, T, Uchida, A, Kodama, K, et al. Aggressive pulmonary metastasectomy for soft tissue sarcomas. Cancer. 1993;72(6):1919-1925. doi:10.1002/1097-0142(19930915)72:6<1919::aid-cncr2820720621>3.0.co;2-d
Google Scholar | Crossref | Medline11. Espat, N, Bilsky, M, Lewis, J, Leung, D, Brennan, MJC. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients. Cancer. 2002;94(10):2706-2711. doi:10.1002/cncr.10554
Google Scholar | Crossref | Medline12. Judson, I, Verweij, J, Gelderblom, H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415-423. doi:10.1016/s1470-2045(14)70063-4
Google Scholar | Crossref | Medline | ISI13. Yamamoto, Y, Kanzaki, R, Kanou, T, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24(7):863-870. doi:10.1007/s10147-019-01422-0
Google Scholar | Crossref | Medline14. Mizuno, T, Taniguchi, T, Ishikawa, Y, et al. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Eur J Cardiothorac Surg. 2013;43(4):795-799. doi:10.1093/ejcts/ezs419
Google Scholar | Crossref | Medline15. Dear, R, Kelly, P, Wright, G, Stalley, P, McCaughan, B, Tattersall, M. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia Pac J Clin Oncol. 2012;8(3):292-302. doi:10.1111/j.1743-7563.2012.01521.x
Google Scholar | Crossref | Medline16. Matsuoka, M, Onodera, T, Yokota, I, et al. Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database. Clin Transl Oncol. 2021. doi:10.1007/s12094-021-02646-1
Google Scholar | Crossref | Medline17. Lindner, L, Litière, S, Sleijfer, S, et al. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: an exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Int J Cancer. 2018;142(12):2610-2620. doi:10.1002/ijc.31286
Google Scholar | Medline18. Italiano, A, Mathoulin-Pelissier, S, Cesne, A, et al. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011;117(5):1049-1054. doi:10.1002/cncr.25538
Google Scholar | Crossref | Medline19. Sawamura, C, Springfield, D, Marcus, K, Perez-Atayde, A, Gebhardt, M. Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities. Clin Orthop Relat Res. 2010;468(11):3019-3027. doi:10.1007/s11999-010-1398-1
Google Scholar | Crossref | Medline20. RStudio Team R . Integrated Development for R. Available at: http://www.rstudio.com/. Accessed June 21, 2017.
Google Scholar21. R RDCT . A Language and Environment for Statistical Computing, version 2.0-0. The R Foundation for Statistical Computing; Vienna, Austria: 2011.
Google Scholar22. Vickers, A, Elkin, E. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574. doi:10.1177/0272989×06295361
Google Scholar | SAGE Journals | ISI23. Kawamoto, T, Hara, H, Morishita, M, et al. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma. Clin Exp Metastasis. 2020;37(4):509-517. doi:10.1007/s10585-020-10038-y
Google Scholar | Crossref | Medline24. Xie, L, Huang, W, Wang, H, Zheng, C, Jiang, J. Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study. J Orthop Surg Res. 2020;15(1):32. doi:10.1186/s13018-020-1571-5
Google Scholar | Crossref | Medline25. Huang, X, Zhao, J, Bai, J, et al. Risk and clinicopathological features of osteosarcoma metastasis to the lung: a population-based study. J Bone Oncol. 2019;16:100230. doi:10.1016/j.jbo.2019.100230
Google Scholar | Crossref | Medline26. Song, K, Song, J, Lin, K, et al. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End results population-based study. Int Orthop. 2019;43(8):1983-1991. doi:10.1007/s00264-019-04348-4
Google Scholar | Crossref | Medline27. Guillou, L, Coindre, J, Bonichon, F, et al. Comparative study of the national cancer institute and French federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350-362. doi:10.1200/jco.1997.15.1.350
Google Scholar | Crossref | Medline | ISI28. Coindre, J, Terrier, P, Guillou, L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French federation of cancer centers sarcoma group. Cancer. 2001;91(10):1914-1926. doi:10.1002/1097-0142(20010515)91:10<1914::aid-cncr1214>3.0.co;2-3
Google Scholar | Crossref | Medline29. Trassard, M, Le Doussal, V, Hacène, K, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001;19(2):525-534. doi:10.1200/jco.2001.19.2.525
Google Scholar | Crossref | Medline30. Munajat, I, Zulmi, W, Norazman, M, Wan Faisham, W. Tumour volume and lung metastasis in patients with osteosarcoma. J Orthop Surg (Hong Kong). 2008;16(2):182-185. doi:10.1177/230949900801600211
Google Scholar | SAGE Journals31. Emori, M, Tsuchie, H, Nagasawa, H, et al. Early lymph node metastasis may predict poor prognosis in soft tissue sarcoma. Int J Surg Oncol. 2019;2019:6708474. doi:10.1155/2019/6708474
Google Scholar | Medline32. Johannesmeyer, D, Smith, V, Cole, D, Esnaola, N. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013;206(3):289-295. doi:10.1016/j.amjsurg.2012.10.043
Google Scholar | Crossref | Medline33. Chudgar, N, Brennan, M, Munhoz, R, et al. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Am Coll Surg. 2017;154(1):319-330.e1. doi:10.1016/j.jtcvs.2017.02.061
Google Scholar34. Carbonnaux, M, Brahmi, M, Schiffler, C, et al. Very long-term survivors among patients with metastatic soft tissue sarcoma. J Thorac Cardiovasc Surg. 2019;8(4):1368-1378. doi:10.1002/cam4.1931
Google Scholar35. Predina, J, Puc, M, Bergey, M, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6(5):913-919. doi:10.1097/JTO.0b013e3182106f5c
Google Scholar | Crossref | Medline36. Dossett, L, Toloza, E, Fontaine, J, et al. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015;112(1):103-106. doi:10.1002/jso.23961
Google Scholar | Crossref | Medline37. Krishnan, C, Kim, H, Park, J, Han, I. Outcome after surgery for extremity soft tissue sarcoma in patients presenting with metastasis at diagnosis. Am J Clin Oncol. 2018;41(7):681-686. doi:10.1097/coc.0000000000000346
Google Scholar | Crossref | Medline38. Constantinidou, A, van der Graaf, W. The fate of new fosfamides in phase III studies in advanced soft tissue sarcoma. Eur J Cancer. 2017;84:257-261. doi:10.1016/j.ejca.2017.07.043
Google Scholar | Crossref | Medline39. Comen, E, Norton, L, Massagué, J. Clinical implications of cancer self-seeding. Eur J Cancer. 2011;8(6):369-377. doi:10.1038/nrclinonc.2011.64
Google Scholar40. Zhang, Y, Ma, Q, Liu, T, et al. Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms. Nat Rev Clin Oncol. 2014;140(2):329-340. doi:10.1007/s00432-013-1561-7
Google Scholar41. Seddon, B, Strauss, S, Whelan, J, et al. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol. 2017;18(10):1397-1410. doi:10.1016/s1470-2045(17)30622-8
Google Scholar | Crossref | Medline42. Tap, W, Wagner, A, Schöffski, P, et al. Effect of doxorubicin plus olaratumab versus doxorubicin plus placebo on survival in patients With advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial. JAMA. 2020;323(13):1266-1276. doi:10.1001/jama.2020.1707
Google Scholar | Crossref | Medline43. Grünwald, V, Karch, A, Schuler, M, et al. Randomized comparison of pazopanib and doxorubicin as first-line treatment in patients With metastatic soft tissue sarcoma age 60 years or older: results of a German Intergroup Study. J Clin Oncol. 2020;38(30):3555-3564. doi:10.1200/jco.20.00714
Google Scholar | Crossref | Medline44. Singhi, E, Moore, D, Muslimani, AJP. Metastatic soft tissue sarcomas: a review of treatment and new pharmacotherapies. J Clin Oncol. 2018;43(7):410-429.
Google Scholar45. In, G, Hu, J, Tseng, W. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017;9(8):533-550. doi:10.1177/1758834017712963
Google Scholar | SAGE Journals | ISI46. Tetta, C, Londero, F, Micali, L, et al. Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma. Clin Oncol (R Coll Radiol). 2020;32(5):303-315. doi:10.1016/j.clon.2020.01.005
Google Scholar | Crossref | Medline